Annals of Indian Academy of Neurology
  Users Online: 1346 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size

Table of Contents
Year : 2013  |  Volume : 16  |  Issue : 3  |  Page : 452-453

Reversible dementia as presenting manifestation of racemose neurocysticercosis

Department of Neurology, SMS Medical College, Jaipur, Rajasthan, India

Date of Web Publication26-Aug-2013

Correspondence Address:
Rajendra Singh Jain
126, Janakpuri II, Imli Ka Phatak, Jaipur 302 005, Rajasthan
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0972-2327.116941

Rights and Permissions


How to cite this article:
Jain RS, Nagpal K, Handa R. Reversible dementia as presenting manifestation of racemose neurocysticercosis. Ann Indian Acad Neurol 2013;16:452-3

How to cite this URL:
Jain RS, Nagpal K, Handa R. Reversible dementia as presenting manifestation of racemose neurocysticercosis. Ann Indian Acad Neurol [serial online] 2013 [cited 2021 Jun 19];16:452-3. Available from:


We read with great interest the article "reversible dementia as presenting manifestation of racemose neurocysticercosis (NCC)" by Sharma et al. (2013). [1] We certainly agree with the fact that evolution of cyst as seen in racemose NCC is not appreciated in parenchymal form. The prevalence of parenchymal cysticercosis is indeed more common in Indian scenario as compared with its racemose form; hence, sensitizing clinicians regarding varied presentations of NCC is essential.

We have also come across a case of racemose NCC recently, who presented with recurrent episodes of seizures. Magnetic resonance images (MRI) in our case showed the presence of a large multi-lobed cyst in the right temporal lobe, which was subjected to surgical excision and histopathology proved it to be of racemose form of NCC.

The reported here patient had dementia of subcortical type, but the mechanism resulting in dementia has not been explained by the authors. Curiously, apart from the enzyme-linked immunosorbent assay for immunoglobulin G antibodies for NCC, the detailed findings on cerebrospinal fluid (CSF) analysis have not been mentioned as cisternal NCC can often result in basal meningitis.

Furthermore, the reason patient was subjected to initially high dose steroids and later on oral corticosteroids after discharge when there was neither perilesional edema nor signs of impending herniation are difficult to understand.

Instead of endoscopic removal of third ventricular cyst that should have been contemplated in the same sitting, authors opted only for ventriculoperitoneal shunting as a counter measure for obstructive hydrocephalus and therefore the case is not histopathologically proven.

Racemose NCC has variable presentation depending on their location resulting in basal arachnoiditis, meningeal fibrosis, adhesions and impairment of CSF flow. [2] Because the cysts lie in cisterns and sulci, they cause focal dilatation of these CSF spaces resulting in the mass effect on adjacent brain parenchyma. [3] Whereas, supratentorial cysts commonly produce epilepsy while those situated in the basal ganglia may give rise to manifestations simulating parkinsonism. [4]

Surgical removal of cysts has been the well-established treatment for NCC characterized by giant subarachnoid cysts or racemose form of NCC. There is a common consensus for the endoscopic removal of cysts confined to ventricles. [5],[6]

Racemose cysticercosis not a commonly encountered clinical entity, but still can pose a challenge as it did in this particular patient. However, in an endemic region as ours NCC should always be prominent differential considered for any cystic lesion on MRI and index of suspicion toward a racemose variety should be always there in the presence of a subarachnoid-cisternal cyst.

   References Top

1.Sharma S, Modi M, Lal V, Prabhakar S, Bhardwaj A, Sehgal R. Reversible dementia as a presenting manifestation of racemose neurocysticercosis. Ann Indian Acad Neurol 2013;16:88-90.  Back to cited text no. 1
[PUBMED]  Medknow Journal  
2.Couldwell WT, Zee CS. Parasitic infestations. In: Wilkins RH, Rengachary SS, editors. Neurosurgery. New York: McGraw-Hill; 1996. p. 3395-403.  Back to cited text no. 2
3.Whiteman ML, Bowen BC, Post MJ, Bell MD. Intracranial infections. In: Atlas SW, editor. Magnetic Resonance Imaging of the Brain and Spine. 2 nd ed. Philadelphia: Lippincott-Raven; 1996. p. 707-72.  Back to cited text no. 3
4.Bickerstaff ER, Cloake PC, Hughes B, Smith WT. The racemose form of cerebral cysticercosis. Brain 1952;75:1-18.  Back to cited text no. 4
5.García HH, Evans CA, Nash TE, Takayanagui OM, White AC Jr, Botero D, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002;15:747-56.  Back to cited text no. 5
6.Proaño JV, Madrazo I, Avelar F, López-Félix B, Díaz G, Grijalva I. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med 2001;345:879-85.  Back to cited text no. 6


Print this article  Email this article


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (353 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


 Article Access Statistics
    PDF Downloaded35    
    Comments [Add]    

Recommend this journal